20 hours Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal
The next few months will be crucial for obesity players Eli Lilly, Novo Nordisk and Amgen.
Amgen (AMGN) · Eli Lilly (LLY)
XThe next few months will be crucial for obesity players Eli Lilly, Novo Nordisk and Amgen.
Amgen (AMGN) · Eli Lilly (LLY)
X